Skip to content
10-Q

Quarterly Report

Rapid Therapeutic Science Laboratories, Inc.

0001393905-22-000447

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 10, 2022 7.75M sh
Capex Q3 2022 · Sep 30, 2022 $354.8K
Capex Q3 2022 · Sep 30, 2021 $117.17K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$799.66K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$1.66M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $0
Cash And Equivalents Q3 2022 · Dec 31, 2021 $192.48K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$3.09M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$1.38M
Current Liabilities Q3 2022 · Sep 30, 2022 $4.91M
Current Liabilities Q3 2022 · Dec 31, 2021 $3.05M
Total Liabilities Q3 2022 · Sep 30, 2022 $5.37M
Total Liabilities Q3 2022 · Dec 31, 2021 $3.58M
Current Assets Q3 2022 · Sep 30, 2022 $237.57K
Current Assets Q3 2022 · Dec 31, 2021 $419.16K
Total Assets Q3 2022 · Sep 30, 2022 $2.29M
Total Assets Q3 2022 · Dec 31, 2021 $2.2M
Eps Basic Q3 2022 · Sep 30, 2022 −$0.03
Eps Basic Q3 2022 · Sep 30, 2022 −$0.24
Eps Basic Q3 2022 · Sep 30, 2021 −$0.08
Eps Basic Q3 2022 · Sep 30, 2021 −$0.22
Sga Expense Q3 2022 · Sep 30, 2022 $345.66K
Sga Expense Q3 2022 · Sep 30, 2022 $1.21M
Sga Expense Q3 2022 · Sep 30, 2021 $490.66K
Sga Expense Q3 2022 · Sep 30, 2021 $1.52M
Net Income Q3 2022 · Sep 30, 2022 −$227.08K
Net Income Q3 2022 · Sep 30, 2022 −$1.84M
Net Income Q3 2022 · Jun 30, 2022 −$36.84K
Net Income Q3 2022 · Mar 31, 2022 −$1.58M
Net Income Q3 2022 · Sep 30, 2021 −$583.44K
Net Income Q3 2022 · Sep 30, 2021 −$1.65M
Net Income Q3 2022 · Jun 30, 2021 −$535.89K
Net Income Q3 2022 · Mar 31, 2021 −$533.75K
Gross Profit Q3 2022 · Sep 30, 2022 $0
Gross Profit Q3 2022 · Sep 30, 2022 $0
Gross Profit Q3 2022 · Sep 30, 2021 $50
Gross Profit Q3 2022 · Sep 30, 2021 $274
Cost Of Revenue Q3 2022 · Sep 30, 2022 $0
Cost Of Revenue Q3 2022 · Sep 30, 2022 $0
Cost Of Revenue Q3 2022 · Sep 30, 2021 $0
Cost Of Revenue Q3 2022 · Sep 30, 2021 $200
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2021 $50
Revenue Q3 2022 · Sep 30, 2021 $474